calendar
10 catalysts · 2,925 8k filing · 558 earnings · 108 phase 2 completion · 50 phase 1 completion · 28 phase 1 2 completion · 22 phase 1 initiation
next 91 dayslessmore
MonWedFri
10 catalysts · 2,925 8k filing · 558 earnings · 108 phase 2 completion · 50 phase 1 completion · 28 phase 1 2 completion · 22 phase 1 initiation
Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization
Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy
Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion
Therapy area: Ophthalmology. Indication: Diabetic Retinopathy
Therapy area: Ophthalmology. Indication: Diabetic Macular Edema
Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease
Prescription Drug User Fee Act goal date of July 17, 2026
action date of January 4, 2027
action date of Jan. 21, 2027